Cue Health Inc.
HLTHQ Healthcare Health Information Services
Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
Follow HLTHQ
Cue Health Inc. (HLTHQ) EV/Sales
As of 16 October 2026, Cue Health Inc. (HLTHQ) trades at a EV/Sales of −1.1×. Over the past ten years it has ranged from −1.1× (October 2026) to 2.0× (September 2021) — the current reading is the lowest in ten years. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2023 | −0.7× | — |
| FY2022 | 0.2× | (67.20%) |
| FY2021 | 0.5× | (77.18%) |
| FY2020 | 2.0× | 0.00% |
| FY2019 | 2.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Dec 2023 | −0.7× | — |
| Sep 2023 | −0.2× | — |
| Jun 2023 | −0.3× | — |
| Mar 2023 | 0.3× | 91.94% |
| 11 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ACON Aclarion, Inc. compare | −137× |
| HLTHQ Cue Health Inc. | −1.1× |
| ZCMD Zhongchao Inc. compare | −0.4× |
| ETAOF ETAO International Co., Ltd. compare | n/m |
| VSEED VSee Health, Inc. compare | 0.2× |
| HCTI Healthcare Triangle, Inc. compare | 0.4× |
| RNLXY Renalytix plc - Sponsored ADR compare | 2.5× |
| BFRG Bullfrog AI Holdings Inc. compare | 7.0× |
| MGRX Mangoceuticals, Inc. compare | 15.6× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)